Eurosai   

                                                          Para acceder directamente al contenido principal pulsa enter
  1. Databases
  2. Audits
  3. Does the Medical Treatment Risk Fund operate for the benefit of patients?

Does the Medical Treatment Risk Fund operate for the benefit of patients?

Audit Id 1572425474640
Title Does the Medical Treatment Risk Fund operate for the benefit of patients?
Title in original language

No ārstniecības riska fonda izmaksāto atlīdzību regulēšanas procesa atbilstība normatīvo aktu prasībām

Latvian

Year 2019
Subject

Health and Social Care (incl. Welfare Benefits)

Type

Compliance/Legality

Performance

Type of performance

Performed by single SAI

Comments Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients' rights in cross-border healthcare requires the Member States of the European Union to establish mechanisms enabling the patient to assert his or her rights and to receive compensation if the damage is caused to his or her health during the medical treatment process. Following the requirements of the Directive, according to the example of Sweden and Denmark, the Medical Treatment Risk Fund (hereinafter referred to as ‘the Fund’) was created and launched in Latvia on 23 Oct 2013. The Fund is under the responsibility of the government, and two authorities: Health Inspectorate and the National Health Service. Five years have passed since the establishment of the Fund, and over the years, the Fund has received more than 900 patient claims, has made more than 200 decisions recognizing the existence of the damage caused and has paid compensation of 4.4 million euro to patients. Therefore, the aim of the audit was to assess whether the established model of protection of patient rights has reached its primary goal. The following criteria have been used in the audit to assess the performance of the Fund: is the Fund accessible to the patient, does the Fund review patient claims in due time, is the procedure for determining the amount of the compensation understandable to the patient, does the financial engineering process of the Fund comply with the requirements of the regulatory enactments, and is improvement of the Fund’s operation ensured?
Author

Latvia

Materials

Summary

Latvian

Have a look

Press release

Latvian

View

Summary

Latvian

Summary of Audit Report in Latvian

Audit report

Latvian

Download report

Press release

English

View

Summary

English

See summary
Contact
State Audit Office of Latvia, 50 Skanstes Street, Riga, LV-1013, Phone: +371 67017500
lrvk@lrvk.gov.lv
http://www.lrvk.gov.lv
  • <fmt:message key='org.eurosai.action.EmailPage' />
  • <fmt:message key='org.eurosai.action.PdfPage' />
  • <fmt:message key='org.eurosai.action.PrintPage' />

This site is managed by EUROSAI - Legal disclaimer